GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » DT&CRO Co Ltd (XKRX:383930) » Definitions » Capital Expenditure

DT&CRO Co (XKRX:383930) Capital Expenditure : ₩-14,699.76 Mil (TTM As of Mar. 2024)


View and export this data going back to 2022. Start your Free Trial

What is DT&CRO Co Capital Expenditure?

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

DT&CRO Co's cash flow for capital expenditures for the three months ended in Mar. 2024 was ₩-3,561 Mil. Its cash flow for capital expenditures for the trailing twelve months (TTM) ended in Mar. 2024 was ₩-14,699.76 Mil.

DT&CRO Co Capital Expenditure Historical Data

The historical data trend for DT&CRO Co's Capital Expenditure can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

DT&CRO Co Capital Expenditure Chart

DT&CRO Co Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Capital Expenditure
-3,087.30 -8,051.17 -14,868.40 -17,056.40

DT&CRO Co Quarterly Data
Jun21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Capital Expenditure Get a 7-Day Free Trial Premium Member Only Premium Member Only -5,918.08 -4,906.62 -2,760.69 -3,471.01 -3,561.44

DT&CRO Co Capital Expenditure Calculation

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Capital Expenditure for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-14,699.76 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

DT&CRO Co (XKRX:383930) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » DT&CRO Co Ltd (XKRX:383930) » Definitions » Capital Expenditure
Comparable Companies
XKRX:298060 XKRX:065650 XKRX:299660 XKRX:142760 XKRX:115180 XKRX:032790 XKRX:222110 XKRX:036480 XKRX:456570 XKRX:208340 OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XBRU:ARGX HKSE:02269 BNTX
Traded in Other Exchanges
N/A
Address
28, Baengnyeong-ro 20beon-gil, 2nd, 3rd, 4th floor, Na-dong, Cheoin-gu, Gyeonggi-do (Yubang-dong), Yongin-si, KOR, 17042
Website
http://www.dtncro.com
DT&CRO Co Ltd conducts a series of consigned research, from non-clinical GLP toxicity, PK, and efficacy tests required for licensing of pharmaceuticals, chemicals, health functional foods, cosmetics and medical devices, to analysis, bioactivity, clinical trials, and licensing consulting. provided as a service.

DT&CRO Co (XKRX:383930) Headlines

No Headlines